| 生物活性 | |||
|---|---|---|---|
| 描述 | AVE3085 is recognized as a potent enhancer of endothelial nitric oxide synthase (eNOS), being employed in the management of cardiovascular diseases[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
3.15mL 0.63mL 0.32mL |
15.76mL 3.15mL 1.58mL |
31.52mL 6.30mL 3.15mL |
| 参考文献 |
|---|